“The establishment of an advisory council will help new medical device regulations transition smoothly in Vietnam.”

David Vo
General Manager
Asia Actual VietNam

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Vietnamese MOH Establishes New Medical Device Advisory Council

Published on: November 20, 2020

Prof. Dr. Nguyen Thanh Long, Minister of Health, awarded the Decision to establish an Advisory Council to license the circulation of medical equipment. Prof. Dr. Le Quang Cuong, former Deputy Minister of Health, will become the President and Chairman of the Association.

Council is to Advise on New License Issuance and Renewals

On November 18, 2020, the Vietnamese Ministry of Health (MOH) released Decision No. 4353 / QD-BYT officially establishing an Advisory Council to oversee the efficient and transparent implementation of new medical device rules. The council will be led by Dr. Le Quant Cuong, the former Deputy Minister of Health, and is tasked with overseeing new registrations of higher risk devices and the extension of existing medical equipment registrations. The council will have 17 members and is scheduled to begin work in May 2021.

The formation of the Council is seen as an important step to a smooth implementation of the new medical device regulations in Vietnam which are scheduled to come into effect on January 1, 2022.  Depending on the Council’s progress, there is potential that the MOH could release new guidance in Q2 of 2021 and begin issuing Class B, C, and D product licenses as early as Q3 or Q4 of 2021.

Current Requirements in Vietnam

Currently, the Vietnamese regulations are in transition from Circular 30 to Decree 36 with a full transition completed in 2022. Currently, only Class A products and specific Class B, C, and D, as designated in Circular 30, are required to have a Market Authorization license (MAH) to clear customs. Products not found on the Circular listing may now clear Customs and sold in Vietnam without an Import License until December 31, 2021. However, medical devices should have their products classification confirmed by a local, qualified classification agent to ensure expeditious customs clearance. From January 1, 2022, these devices will also require a Market Authorization License (under the new Rules).  Medical devices manufacturers should work with their local agents to determine the specific regulatory requirements for their portfolio now and after January 1, 2022.

Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with questions or support requests.

Blog Posts

Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more
Thai FDA Documentation Exemptions for Concise and Full Regulatory Pathways

Thai FDA Regulatory Documentation Exemptions

March 12, 2024: the Thai FDA released draft guidance updating the list of required documentation for Full and Concise Evaluation. For manufacturers registering a medical device in Thailand, certain documents are no longer required.
Read more
Hong Kong MDD adds Singapore HSA to Reference Country List

Hong Kong MDD Adds Singapore as Reference Country

Starting April 2nd, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the the Health Sciences Authority (HSA) of Singapore as a support of compliance of medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS.
Read more